Double-masked, multicenter study of an estradiol matrix transdermal delivery system (Alora™) versus placebo in postmenopausal women experiencing menopausal symptoms
- 1 November 1996
- journal article
- clinical trial
- Published by Elsevier in Clinical Therapeutics
- Vol. 18 (6) , 1093-1105
- https://doi.org/10.1016/s0149-2918(96)80064-6
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Use of menopausal estrogens and medroxyprogesterone in the United States, 1982–1992Published by Wolters Kluwer Health ,2000
- Efficacy and tolerance of Menorest® compared to Premarin® in the treatment of postmenopausal women. A randomised, multicentre, double-blind, double-dummy studyMaturitas, 1995
- Clinical experience with a seven-day estradiol transdermal system for estrogen replacement therapyAmerican Journal of Obstetrics and Gynecology, 1995
- Acceptability and skin reactions to transdermal estrogen replacement therapy in relation to climateMaturitas, 1994
- Quality of life after the menopause: Influence of hormonal replacement therapyAmerican Journal of Obstetrics and Gynecology, 1994
- Long-term hormone replacement treatment in menopause: new choices, old apprehensions, recent findingsMaturitas, 1993
- Estraderm for osteoporosisGeriatric Nursing, 1992
- Transdermal EstradiolDrugs, 1990
- Estrogen Replacement Therapy and the Estraderm Transdermal SystemThe Nurse Practitioner, 1990
- Biologic Effects of Transdermal EstradiolNew England Journal of Medicine, 1986